Background illustration for clinical trials search

Paid Clinical Trials Olathe

Discover 707 paid clinical trials in Olathe, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

for
Transthyretin-Mediated Amyloidosis, ATTR Amyloidosis
Location: Kansas City KS, Iowa City IA, Austin TX, Columbus OH,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 0+

Code: NCT04561518

Recruiting

Fecal Microbiota Transplant National Registry

for
Fecal Microbiota Transplantation,
Location: Kansas City KS, Rochester MN, Madison WI, Maywood IL,
Sponsor: American Gastroenterological Association

Sex: All

Age: 0+

Code: NCT03325855

Recruiting

MEASuRE: Metreleptin Effectiveness And Safety Registry

for
Generalised Lipodystrophy, Partial Lipodystrophy
Location: Kansas City KS, Chicago IL, Dallas TX, Ann Arbor MI,
Sponsor: Chiesi Farmaceutici S.p.A.

Sex: All

Age: 0+

Code: NCT02325674

Recruiting

A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

for
Acute Myeloid Leukemia, Myelodysplastic Syndromes
Location: Kansas City KS, New York NY, Duarte CA
Sponsor: GluBio Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06146257

Phase1, Recruiting

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

for
Proteinuric Kidney Disease
Location: Kansas City KS, City of Saint Peters MO, St Louis MO,
Sponsor: Maze Therapeutics

Sex: All

Age: 18 - 68

Code: NCT06830629

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

for
Sepsis, Acute Kidney Injury
Location: Kansas City KS, Detroit MI, Winston-Salem NC,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07215702

Phase2, Recruiting

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Kansas City KS, St Louis MO, Memphis TN, Dallas TX,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07358078

Recruiting

A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

for
Bronchiectasis With Pseudomonas Aeruginosa Colonization
Location: Kansas City KS, St Louis MO, Mansfield TX, Ann Arbor MI,
Sponsor: AstraZeneca

Sex: All

Age: 12+

Code: NCT07088926

Phase2, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Cancer, PDAC,
Location: Lawrence KS, Kansas City MO, Omaha NE, Sioux Falls SD,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07252232

Phase3, Recruiting

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

for
Metastatic Gastric Adenocarcinoma,
Location: Kansas City KS, Lincoln NE, Bridgeton MO, Hinsdale IL,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07043400

Phase3, Recruiting

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

for
Asthma
Location: Kansas City KS, Kansas City MO, Lincoln NE, Omaha NE,
Sponsor: AstraZeneca

Sex: All

Age: 12 - 17

Code: NCT06307665

Phase3, Recruiting

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

for
High Risk Cardiovascular Disease, Hypertension,
Location: Kansas City KS, Kansas City MO, Topeka KS,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07181109

Phase3, Recruiting

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

for
Severe Hypertriglyceridemia
Location: Kansas City KS, St Louis MO, North Platte NE,
Sponsor: Arrowhead Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06880770

Phase3, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Kansas City KS, Kansas City MO, Jefferson City MO,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase3, Recruiting

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Kansas City KS, St Louis MO, Rochester MN, Plano TX,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07052903

Phase3, Recruiting

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

for
Lewy Body Dementia Psychosis
Location: Kansas City KS, Tulsa OK, Chicago IL, Aurora CO,
Sponsor: ACADIA Pharmaceuticals Inc.

Sex: All

Age: 55 - 70+

Code: NCT07029581

Phase2, Recruiting

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

for
COPD, Emphysema
Location: Kansas City KS, Peoria IL, Chicago IL, Milwaukee WI,
Sponsor: Apreo Health, Inc.

Sex: All

Age: 40 - 70+

Code: NCT06891755

Recruiting

The Fourth Left Atrial Appendage Occlusion Study

for
Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism
Location: Kansas City KS, West Des Moines IA, Tulsa OK,
Sponsor: Hamilton Health Sciences Corporation

Sex: All

Age: 18+

Code: NCT05963698

Recruiting

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Kansas City KS, Hannibal MO, Tulsa OK, Oklahoma City OK,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06878261

Phase3, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Kansas City KS, Omaha NE, St Louis MO, Iowa City IA,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase3, Recruiting